Review
. 2015 Nov; 36(12):822-846.
doi: 10.1016/j.tips.2015.08.009.

Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease

Murugan Kalimutho 1 Kate Parsons 2 Deepak Mittal 3 J Alejandro López 4 Sriganesh Srihari 5 Kum Kum Khanna 6 
Affiliations
  • PMID: 26538316
  •     95 citations

Abstract

Triple-negative breast cancers (TNBCs) constitute a heterogeneous subtype of breast cancers that have a poor clinical outcome. Although no approved targeted therapy is available for TNBCs, molecular-profiling efforts have revealed promising molecular targets, with several candidate compounds having now entered clinical trials for TNBC patients. However, initial results remain modest, thereby highlighting challenges potentially involving intra- and intertumoral heterogeneity and acquisition of therapy resistance. We present a comprehensive review on emerging targeted therapies for treating TNBCs, including the promising approach of immunotherapy and the prognostic value of tumor-infiltrating lymphocytes. We discuss the impact of pathway rewiring in the acquisition of drug resistance, and the prospect of employing combination therapy strategies to overcome challenges towards identifying clinically-viable targeted treatment options for TNBC.

Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Sriganesh Srihari, Jitin Singla, Limsoon Wong, Mark A Ragan.
Biol Direct, 2015 Oct 03; 10. PMID: 26427375    Free PMC article.
Metastatic breast cancer: The Odyssey of personalization.
A Sonnenblick, N Pondé, M Piccart.
Mol Oncol, 2016 Jul 20; 10(8). PMID: 27430154    Free PMC article.
Review.
Influence of wound fluid on chemotherapy sensitivity in primary breast cancer cells.
Yingchao Zhang, Dong Yan, +4 authors, Caigang Liu.
Oncotarget, 2016 Aug 20; 7(40). PMID: 27542254    Free PMC article.
Targeting DNA Replication Stress for Cancer Therapy.
Jun Zhang, Qun Dai, Dongkyoo Park, Xingming Deng.
Genes (Basel), 2016 Aug 23; 7(8). PMID: 27548226    Free PMC article.
Review.
High levels of sphingolipids in human breast cancer.
Masayuki Nagahashi, Junko Tsuchida, +5 authors, Toshifumi Wakai.
J Surg Res, 2016 Aug 28; 204(2). PMID: 27565080    Free PMC article.
Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer.
Xi Zhang, Nadia Harbeck, Udo Jeschke, Sophie Doisneau-Sixou.
J Cancer Res Clin Oncol, 2016 Dec 28; 143(7). PMID: 28025696
Review.
Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.
Nyam-Osor Chimge, Sara Ahmed-Alnassar, Baruch Frenkel.
Cell Cycle, 2017 Jan 06; 16(4). PMID: 28055379    Free PMC article.
Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.
Xiaoran Liu, Huiping Li, +6 authors, Fengling Wan.
Cancer Med, 2017 Jan 31; 6(3). PMID: 28135048    Free PMC article.
Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference Transcriptomes.
Yang Liu, Xiaoyao Yin, +7 authors, Hui Bai.
Genes (Basel), 2017 Mar 02; 8(3). PMID: 28245581    Free PMC article.
Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Huizhi Sun, Danfang Zhang, +10 authors, Shuya Sun.
Cancer Biol Ther, 2017 Mar 10; 18(4). PMID: 28278077    Free PMC article.
In vivo models in breast cancer research: progress, challenges and future directions.
Ingunn Holen, Valerie Speirs, Bethny Morrissey, Karen Blyth.
Dis Model Mech, 2017 Apr 07; 10(4). PMID: 28381598    Free PMC article.
Review.
The calcium-cancer signalling nexus.
Gregory R Monteith, Natalia Prevarskaya, Sarah J Roberts-Thomson.
Nat Rev Cancer, 2017 Apr 08; 17(6). PMID: 28386091
Highly Cited. Review.
The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer.
Isabelle Bar, Ahmad Merhi, +4 authors, Paul Delrée.
J Histochem Cytochem, 2017 Apr 14; 65(6). PMID: 28402752    Free PMC article.
Targeted therapies in breast cancer: New challenges to fight against resistance.
Viviana Masoud, Gilles Pagès.
World J Clin Oncol, 2017 Apr 26; 8(2). PMID: 28439493    Free PMC article.
Review.
DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.
Giuliana De Gregoriis, Juliene Antonio Ramos, +8 authors, Marcelo Alex de Carvalho.
Cancer Biol Ther, 2017 May 06; 18(6). PMID: 28475402    Free PMC article.
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Bo Chen, Jin Wang, +7 authors, Xiaoming Xie.
J Exp Clin Cancer Res, 2017 May 13; 36(1). PMID: 28494797    Free PMC article.
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
Chun-Yu Liu, Kuen-Feng Chen, +13 authors, Ling-Ming Tseng.
J Mol Med (Berl), 2017 Jun 05; 95(9). PMID: 28578456
Therapeutic Strategies in Triple-Negative Breast Cancer.
Angelo Paradiso, Christian F Singer.
Breast Care (Basel), 2017 Jun 15; 12(1). PMID: 28611534    Free PMC article.
Recent Advances in the Neoadjuvant Treatment of Breast Cancer.
Gábor Rubovszky, Zsolt Horváth.
J Breast Cancer, 2017 Jul 12; 20(2). PMID: 28690648    Free PMC article.
Review.
Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.
Zilan Zhou, Mina Jafari, +4 authors, Susan E Waltz.
Mol Pharm, 2017 Oct 28; 14(12). PMID: 29077410    Free PMC article.
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.
Nalo Hamilton, David Austin, +6 authors, Richard Pietras.
Int J Mol Sci, 2017 Nov 04; 18(11). PMID: 29099049    Free PMC article.
Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
Chen-Shan Chen Woodcock, Yi Huang, +7 authors, Stacy G Wendell.
J Biol Chem, 2017 Nov 22; 293(4). PMID: 29158255    Free PMC article.
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
Chun-Yu Liu, Ka-Yi Lau, +7 authors, Ling-Ming Tseng.
PLoS One, 2017 Dec 21; 12(12). PMID: 29261702    Free PMC article.
A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures.
Amanda M Clark, Manu P Kumar, +6 authors, Alan Wells.
Mol Cell Proteomics, 2018 Jan 22; 17(4). PMID: 29353230    Free PMC article.
Kernelized rank learning for personalized drug recommendation.
Xiao He, Lukas Folkman, Karsten Borgwardt.
Bioinformatics, 2018 Mar 13; 34(16). PMID: 29528376    Free PMC article.
Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer.
Jee Min Chung, Yongsik Jung, +11 authors, Ho Chul Kang.
J Breast Cancer, 2018 Apr 10; 21(1). PMID: 29628988    Free PMC article.
A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness.
Alessandra di Gennaro, Valentina Damiano, +9 authors, Roberta Maestro.
Cell Death Differ, 2018 Apr 19; 25(12). PMID: 29666469    Free PMC article.
Applications of RNA Indexes for Precision Oncology in Breast Cancer.
Liming Ma, Zirui Liang, Hui Zhou, Lianghu Qu.
Genomics Proteomics Bioinformatics, 2018 May 13; 16(2). PMID: 29753129    Free PMC article.
Review.
Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
Rammohan Devulapally, Taehwa Lee, +5 authors, Ramasamy Paulmurugan.
Nanomedicine (Lond), 2018 May 24; 13(9). PMID: 29790803    Free PMC article.
Immunotherapeutic interventions of Triple Negative Breast Cancer.
Zehuan Li, Yiran Qiu, +2 authors, Jin Wang.
J Transl Med, 2018 Jun 01; 16(1). PMID: 29848327    Free PMC article.
Review.
Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells.
Nathan Beals, Praveena S Thiagarajan, +4 authors, Soumitra Basu.
ACS Omega, 2018 Jul 20; 2(11). PMID: 30023561    Free PMC article.
Identification of long non-coding RNA signatures in triple-negative breast cancer.
Tian Tian, Zhouqing Gong, +10 authors, Zhijun Dai.
Cancer Cell Int, 2018 Jul 22; 18. PMID: 30026672    Free PMC article.
The TGFα-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells.
Rosa Mistica C Ignacio, Carla R Gibbs, Eun-Sook Lee, Deok-Soo Son.
Oncotarget, 2018 Jul 24; 9(50). PMID: 30034618    Free PMC article.
Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer.
Xiaoran Liu, Ran Ran, +13 authors, Huiping Li.
Chin J Cancer Res, 2018 Jul 27; 30(3). PMID: 30046226    Free PMC article.
Pharmacological inhibition of store-operated calcium entry in MDA-MB-468 basal A breast cancer cells: consequences on calcium signalling, cell migration and proliferation.
Iman Azimi, Alice H Bong, +4 authors, Gregory R Monteith.
Cell Mol Life Sci, 2018 Aug 15; 75(24). PMID: 30105615
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer.
Murugan Kalimutho, Debottam Sinha, +16 authors, Kum Kum Khanna.
EMBO Mol Med, 2018 Aug 16; 10(9). PMID: 30108112    Free PMC article.
Gold nanoparticles-induced cytotoxicity in triple negative breast cancer involves different epigenetic alterations depending upon the surface charge.
Sunil Kumar Surapaneni, Shafiya Bashir, Kulbhushan Tikoo.
Sci Rep, 2018 Aug 18; 8(1). PMID: 30115982    Free PMC article.
Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells.
Sumi Shrestha, Anabel Sorolla, +2 authors, Gavin R Flematti.
Mar Drugs, 2018 Oct 03; 16(10). PMID: 30275391    Free PMC article.
Association Analysis of Somatic Copy Number Alteration Burden With Breast Cancer Survival.
Linfan Zhang, Nikta Feizi, Chen Chi, Pingzhao Hu.
Front Genet, 2018 Oct 20; 9. PMID: 30337938    Free PMC article.
DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid.
Krysta Mila Coyle, Cheryl A Dean, +4 authors, Paola Marcato.
Cancers (Basel), 2018 Oct 26; 10(11). PMID: 30352973    Free PMC article.
AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.
Kaiming Zhang, Peng Liu, +5 authors, Xiangsheng Xiao.
Front Pharmacol, 2018 Dec 07; 9. PMID: 30505272    Free PMC article.
Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy.
Amita M Vaidya, Zhanhu Sun, +10 authors, Zheng-Rong Lu.
Bioconjug Chem, 2019 Feb 12; 30(3). PMID: 30739442    Free PMC article.
Highly Cited.
Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.
Ton Wang, Chitra Subramanian, +7 authors, Mark S Cohen.
Surgery, 2019 Aug 03; 166(6). PMID: 31371177    Free PMC article.
Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Mengyu Yu, Chengcheng Gai, +5 authors, Wentong Li.
Cancer Sci, 2019 Aug 30; 110(10). PMID: 31464035    Free PMC article.
Metabolomics: a promising diagnostic and therapeutic implement for breast cancer.
Zhanghan Chen, Zehuan Li, Haoran Li, Ying Jiang.
Onco Targets Ther, 2019 Nov 07; 12. PMID: 31686838    Free PMC article.
Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer.
Jiang Yin, Danyang Chen, +9 authors, Hao Liu.
J Cancer, 2019 Nov 26; 10(24). PMID: 31762806    Free PMC article.
Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux.
Stamatia Rontogianni, Sedef Iskit, +2 authors, Maarten Altelaar.
Mol Cell Proteomics, 2019 Nov 28; 19(2). PMID: 31772060    Free PMC article.
Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC.
Renbo Tan, Haoyang Li, +4 authors, Ying Xu.
Sci Rep, 2020 Feb 23; 10(1). PMID: 32080331    Free PMC article.
Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer.
Jing Tang, Prson Gautam, +13 authors, Tero Aittokallio.
NPJ Syst Biol Appl, 2019 Jul 18; 5. PMID: 31312514    Free PMC article.
BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.
Danielle S Chun, Brygida Berse, +6 authors, Julie A Lynch.
Fam Cancer, 2016 Sep 04; 16(1). PMID: 27589855
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.
Jun Tian, Fatmah Al Raffa, +7 authors, Jean-Jacques Lebrun.
Br J Cancer, 2018 Nov 30; 119(12). PMID: 30482914    Free PMC article.
Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Vishnu C Ramani, Clementine A Lemaire, +10 authors, Stefanie S Jeffrey.
Breast Cancer Res, 2019 Aug 30; 21(1). PMID: 31462307    Free PMC article.
Fluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancer.
Dejuan Sun, Lingjuan Zhu, +4 authors, Liang Ouyang.
Cell Prolif, 2017 Nov 03; 51(2). PMID: 29094413    Free PMC article.
p63 at the Crossroads between Stemness and Metastasis in Breast Cancer.
Veronica Gatti, Lucilla Bongiorno-Borbone, +3 authors, Angelo Peschiaroli.
Int J Mol Sci, 2019 Jun 05; 20(11). PMID: 31159154    Free PMC article.
Review.
A new immunotherapy schedule in addition to first-line hormone therapy for metastatic breast cancer patients in a state of clinical benefit during hormone therapy.
Andrea Nicolini, Giuseppe Rossi, +2 authors, Angelo Carpi.
J Mol Med (Berl), 2020 Jan 31; 98(3). PMID: 31996953
Targeted cancer cell delivery of arsenate as a reductively activated prodrug.
Daniela Cioloboc, Donald M Kurtz.
J Biol Inorg Chem, 2020 Mar 20; 25(3). PMID: 32189144
Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
Zhen Zhao, Yuanke Li, +4 authors, Kun Cheng.
Theranostics, 2019 Jul 10; 9(15). PMID: 31285776    Free PMC article.
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition.
Prahlad V Raninga, Andy Lee, +11 authors, Kum Kum Khanna.
Theranostics, 2020 May 07; 10(12). PMID: 32373211    Free PMC article.
Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation.
Ji Eun Park, Joonyoung Park, +11 authors, Wooin Lee.
J Control Release, 2019 Apr 08; 302. PMID: 30954620    Free PMC article.
Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume.
Bernhard Tribukait.
BMC Cancer, 2020 May 20; 20(1). PMID: 32423477    Free PMC article.
Circular RNA hsa_circ_0131242 Promotes Triple-Negative Breast Cancer Progression by Sponging hsa-miR-2682.
Yueting Li, Pengxu Shi, +2 authors, Daqing Jiang.
Onco Targets Ther, 2020 Jun 18; 13. PMID: 32547106    Free PMC article.
Phytochemical profile and antiproliferative effect of Ficus crocata extracts on triple-negative breast cancer cells.
Carlos A Sánchez-Valdeolívar, Patricia Alvarez-Fitz, +10 authors, Miguel A Mendoza-Catalán.
BMC Complement Med Ther, 2020 Jun 24; 20(1). PMID: 32571387    Free PMC article.
Molecular determinants of drug response in TNBC cell lines.
Nathan M Merrill, Eric J Lachacz, +7 authors, Matthew B Soellner.
Breast Cancer Res Treat, 2019 Oct 28; 179(2). PMID: 31655920    Free PMC article.
Opening large-conductance potassium channels selectively induced cell death of triple-negative breast cancer.
Gina Sizemore, Sarah McLaughlin, +7 authors, Han-Gang Yu.
BMC Cancer, 2020 Jun 27; 20(1). PMID: 32586284    Free PMC article.
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
Anna Burguin, Daniela Furrer, +3 authors, Francine Durocher.
PLoS One, 2020 Jun 26; 15(6). PMID: 32584853    Free PMC article.
Brevilin A, a Natural Sesquiterpene Lactone Inhibited the Growth of Triple-Negative Breast Cancer Cells via Akt/mTOR and STAT3 Signaling Pathways.
Zhao Qu, Yushan Lin, +3 authors, Sibao Chen.
Onco Targets Ther, 2020 Jul 02; 13. PMID: 32606754    Free PMC article.
Oxidized ATM promotes breast cancer stem cell enrichment through energy metabolism reprogram-mediated acetyl-CoA accumulation.
Dan Yang, Meixi Peng, +10 authors, Manran Liu.
Cell Death Dis, 2020 Jul 10; 11(7). PMID: 32641713    Free PMC article.
Arnicolide D Inhibits Triple Negative Breast Cancer Cell Proliferation by Suppression of Akt/mTOR and STAT3 Signaling Pathways.
Zhao Qu, Yushan Lin, +3 authors, Sibao Chen.
Int J Med Sci, 2020 Jul 17; 17(11). PMID: 32669950    Free PMC article.
EGFR, BRCA1, BRCA2 and TP53 genetic profile in Moroccan triple negative breast cancer cases.
Farah Jouali, Fatima Zahra El Ansari, +4 authors, Jamal Fekkak.
Int J Mol Epidemiol Genet, 2020 Jul 28; 11(1). PMID: 32714499    Free PMC article.
Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
Yongqi Zhen, Rongyan Zhao, +5 authors, Xian-Li Zhou.
Theranostics, 2020 Jul 30; 10(18). PMID: 32724459    Free PMC article.
LncRNA DLG1-AS1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Downregulating miR-203.
Shuyan Li.
J Breast Cancer, 2020 Sep 11; 23(4). PMID: 32908786    Free PMC article.
ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses.
Iman Azimi, Michael J G Milevskiy, +7 authors, Gregory R Monteith.
Cancers (Basel), 2019 Feb 14; 11(2). PMID: 30754719    Free PMC article.
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
Xuemei Lv, Miao He, +12 authors, Minjie Wei.
Cancer Cell Int, 2019 Jul 13; 19. PMID: 31297036    Free PMC article.
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis.
Nandini Verma, Yaron Vinik, +9 authors, Sima Lev.
Sci Adv, 2020 Sep 17; 6(34). PMID: 32937365    Free PMC article.
Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer.
Sera Lim, Yesol Kim, +10 authors, Jong Hoon Park.
Oncogenesis, 2020 Oct 13; 9(10). PMID: 33041328    Free PMC article.
Knockdown of SERPINE1 reverses resistance of triple‑negative breast cancer to paclitaxel via suppression of VEGFA.
Qian Zhang, Li Lei, Di Jing.
Oncol Rep, 2020 Oct 02; 44(5). PMID: 33000256    Free PMC article.
Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements.
Dima Hattab, Athirah Bakhtiar.
Pharmaceutics, 2020 Oct 03; 12(10). PMID: 33003468    Free PMC article.
Review.
CDK5 Inhibition Abrogates TNBC Stem-Cell Property and Enhances Anti-PD-1 Therapy.
Yuncheng Bei, Nan Cheng, +13 authors, Pingping Shen.
Adv Sci (Weinh), 2020 Nov 27; 7(22). PMID: 33240752    Free PMC article.
Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
Anna A Marusiak, Monika K Prelowska, +11 authors, Dominika Nowis.
Oncogene, 2018 Dec 16; 38(15). PMID: 30552384    Free PMC article.
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis.
Patricia Masso-Welch, Sofia Girald Berlingeri, +7 authors, Yasser Heakal.
Int J Mol Sci, 2018 Dec 28; 20(1). PMID: 30587795    Free PMC article.
Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer.
Murugan Kalimutho, Debottam Sinha, +7 authors, Kum Kum Khanna.
J Exp Clin Cancer Res, 2019 Feb 20; 38(1). PMID: 30777101    Free PMC article.
Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer.
Malamati Kourti, Andrew Westwell, Wen Jiang, Jun Cai.
Oncotarget, 2019 Feb 26; 10(10). PMID: 30800223    Free PMC article.
Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled "chitosome" for improving chemosensitivity of triple negative breast cancer cells.
Xianfu Sun, Haipeng Xu, +3 authors, Suxia Luo.
Drug Deliv Transl Res, 2020 May 13; 11(1). PMID: 32394334
The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis.
Xingfa Huo, Jinming Li, +5 authors, Jiuda Zhao.
BMC Cancer, 2021 Jan 21; 21(1). PMID: 33468087    Free PMC article.
Dormant Tumor Cell Vaccination: A Mathematical Model of Immunological Dormancy in Triple-Negative Breast Cancer.
Reza Mehdizadeh, Seyed Peyman Shariatpanahi, +2 authors, Curzio Rüegg.
Cancers (Basel), 2021 Jan 15; 13(2). PMID: 33440806    Free PMC article.
Efavirenz as a potential drug for the treatment of triple-negative breast cancers.
P-T Chiou, S Ohms, +3 authors, M G Casarotto.
Clin Transl Oncol, 2020 Jun 23; 23(2). PMID: 32566961
Survival outcomes are associated with genomic instability in luminal breast cancers.
Lydia King, Andrew Flaus, Emma Holian, Aaron Golden.
PLoS One, 2021 Feb 04; 16(2). PMID: 33534788    Free PMC article.
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
Shaoxia Fan, Shen Yan, +2 authors, Min Hao.
Onco Targets Ther, 2021 Apr 23; 14. PMID: 33883901    Free PMC article.
Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells.
Jennifer Tsui, Shu Qi, +2 authors, Pnina Brodt.
Biomolecules, 2021 May 01; 11(4). PMID: 33916323    Free PMC article.
CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer.
Ashwini Makhale, Devathri Nanayakkara, +2 authors, Murugan Kalimutho.
Int J Mol Sci, 2021 Jun 03; 22(11). PMID: 34071360    Free PMC article.
IP-10 (CXCL10) Can Trigger Emergence of Dormant Breast Cancer Cells in a Metastatic Liver Microenvironment.
Amanda M Clark, Haley L Heusey, +2 authors, Alan Wells.
Front Oncol, 2021 Jun 15; 11. PMID: 34123844    Free PMC article.
Entelon® (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells.
Daeun You, Yisun Jeong, +6 authors, Sangmin Kim.
Molecules, 2021 Jul 03; 26(12). PMID: 34203721    Free PMC article.
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.
Jihyun Park, Moises J Tacam, +15 authors, Chandra Bartholomeusz.
Breast Cancer Res Treat, 2021 Jul 10; 189(2). PMID: 34241740    Free PMC article.
Embelin downregulated cFLIP in breast cancer cell lines facilitate anti-tumor effect of IL-1β-stimulated human umbilical cord mesenchymal stem cells.
Ya-Han Liang, Jiann-Ming Wu, +2 authors, Hwai-Shi Wang.
Sci Rep, 2021 Jul 21; 11(1). PMID: 34282169    Free PMC article.
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs.
Qitong Wu, Sumit Siddharth, Dipali Sharma.
Cancers (Basel), 2021 Aug 08; 13(15). PMID: 34359598    Free PMC article.
Review.